Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.verified

PSTI

Price:

$1

Market Cap:

$40.85M

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also d...[Read more]

Industry

Biotechnology

IPO Date

2007-12-10

Stock Exchange

NASDAQ

Ticker

PSTI

The ROE as of November 2025 (TTM) for Pluristem Therapeutics Inc. (PSTI) is 21.27%

According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 21.27%. This represents a change of 106.46% compared to the average of 10.30% of the last 4 quarters.

Pluristem Therapeutics Inc. (PSTI) Historical ROE (quarterly & annually)

How has PSTI ROE performed in the past?

The mean historical ROE of Pluristem Therapeutics Inc. over the last ten years is -32.83%. The current 21.27% ROE has changed -164.80% with respect to the historical average. Over the past ten years (40 quarters), PSTI's ROE was at its highest in in the March 2025 quarter at 141.60%. The ROE was at its lowest in in the June 2025 quarter at -131.35%.

Quarterly (TTM)
Annual

Average

-32.83%

Median

-56.44%

Minimum

-161.80%

Maximum

339.81%

Pluristem Therapeutics Inc. (PSTI) ROE by Quarter and Year

Discovering the peaks and valleys of Pluristem Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 76.55%

Maximum Annual ROE = 339.81%

Minimum Annual Increase = -489.46%

Minimum Annual ROE = -161.80%

Quarterly (TTM)
Annual
YearROEChange
2025339.81%-489.46%
2021-87.25%67.91%
2020-51.96%-67.88%
2019-161.80%76.55%
2018-91.65%-0.32%
2017-91.94%50.92%
2016-60.92%43.55%
2015-42.44%-2.10%
2014-43.35%17.76%
2013-36.81%-6.08%

Pluristem Therapeutics Inc. (PSTI) Average ROE

How has PSTI ROE performed in the past?

The current ROE of Pluristem Therapeutics Inc. (PSTI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

66.87%

5-year avg

-10.57%

10-year avg

-32.83%

Pluristem Therapeutics Inc. (PSTI) ROE vs. Peers

How is PSTI’s ROE compared to its peers?

Pluristem Therapeutics Inc.’s ROE is greater than Magenta Therapeutics, Inc. (-34.04%), greater than Rein Therapeutics Inc. (-217.16%), greater than Eyenovia, Inc. (-119.59%), less than Satsuma Pharmaceuticals, Inc. (125.24%), greater than Lumos Pharma, Inc. (-197.75%), greater than Lunai Bioworks Inc. (-385.07%), greater than GreenLight Biosciences Holdings (-1847.24%), greater than Cerecor Inc. (-18.28%), less than LianBio (0.77%), greater than AlloVir, Inc. (-76.00%),

Build a custom stock screener for Pluristem Therapeutics Inc. (PSTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pluristem Therapeutics Inc. (PSTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Pluristem Therapeutics Inc.'s ROE?

How is the ROE calculated for Pluristem Therapeutics Inc. (PSTI)?

What is the highest ROE for Pluristem Therapeutics Inc. (PSTI)?

What is the 3-year average ROE for Pluristem Therapeutics Inc. (PSTI)?

What is the 5-year average ROE for Pluristem Therapeutics Inc. (PSTI)?

How does the current ROE for Pluristem Therapeutics Inc. (PSTI) compare to its historical average?